Abiopharma

🔍 Daniels Eric Joseph (Executive)

Company: KIORA PHARMACEUTICALS INC (KPRX)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 6,533 shares of Common Stock (Direct)
  Date: 2026-03-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 32,670.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 13,067 shares of Stock Option (right to buy) at $1.98 per share (Derivative)
  Date: 2026-03-06 | Code: A | Expires: 2036-04-01 | Exercise: 2027-04-01 | equity_swap_involved: 0 | shares_owned_after: 13,067.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to the reporting person's continuous service through each such vesting date.
• F2: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2027, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.